drugset / Trial / NCT01193504

Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification

NCT01193504

Phase 4 Unknown 100 enrolled Innovative Medical
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to determine if Lotemax eye drops are at least as effective as Pred Forte eye drops, which are the standard of care after cataract surgery.

Timeline

Start
2010-09
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Loteprednol Other / unclassified 0.5 % Topical
Comparator Prednisolone Other / unclassified 1 % Topical

Indications